Pfizer Earnings Estimate
PFE Stock | USD 26.27 0.05 0.19% |
Pfizer |
Pfizer Earnings Estimation Breakdown
The calculation of Pfizer's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Pfizer is estimated to be 0.52 with the future projection ranging from a low of 0.35 to a high of 0.77. Please be aware that this consensus of annual earnings estimates for Pfizer Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.35 Lowest | Expected EPS | 0.77 Highest |
Pfizer Earnings Projection Consensus
Suppose the current estimates of Pfizer's value are higher than the current market price of the Pfizer stock. In this case, investors may conclude that Pfizer is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Pfizer's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2024 | Current EPS (TTM) | |
22 | 67.46% | 0.1 | 0.52 | 0.37 |
Pfizer Earnings History
Earnings estimate consensus by Pfizer Inc analysts from Wall Street is used by the market to judge Pfizer's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Pfizer's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Pfizer Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pfizer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pfizer Earnings per Share Projection vs Actual
Actual Earning per Share of Pfizer refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Pfizer Inc predict the company's earnings will be in the future. The higher the earnings per share of Pfizer, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Pfizer Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Pfizer, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Pfizer should always be considered in relation to other companies to make a more educated investment decision.Pfizer Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-01-30 | 2023-12-31 | -0.22 | 0.1 | 0.32 | 145 | ||
2023-10-31 | 2023-09-30 | -0.34 | -0.17 | 0.17 | 50 | ||
2023-08-01 | 2023-06-30 | 0.57 | 0.67 | 0.1 | 17 | ||
2023-05-02 | 2023-03-31 | 0.98 | 1.23 | 0.25 | 25 | ||
2023-01-31 | 2022-12-31 | 1.05 | 1.14 | 0.09 | 8 | ||
2022-11-01 | 2022-09-30 | 1.39 | 1.78 | 0.39 | 28 | ||
2022-07-28 | 2022-06-30 | 1.78 | 2.04 | 0.26 | 14 | ||
2022-05-03 | 2022-03-31 | 1.47 | 1.67 | 0.2 | 13 | ||
2022-02-08 | 2021-12-31 | 0.87 | 1.08 | 0.21 | 24 | ||
2021-11-02 | 2021-09-30 | 1.09 | 1.34 | 0.25 | 22 | ||
2021-07-28 | 2021-06-30 | 0.97 | 1.07 | 0.1 | 10 | ||
2021-05-04 | 2021-03-31 | 0.77 | 0.93 | 0.16 | 20 | ||
2021-02-02 | 2020-12-31 | 0.48 | 0.42 | -0.06 | 12 | ||
2020-10-27 | 2020-09-30 | 0.71 | 0.72 | 0.01 | 1 | ||
2020-07-28 | 2020-06-30 | 0.66 | 0.78 | 0.12 | 18 | ||
2020-04-28 | 2020-03-31 | 0.73 | 0.8 | 0.07 | 9 | ||
2020-01-28 | 2019-12-31 | 0.58 | 0.55 | -0.03 | 5 | ||
2019-10-29 | 2019-09-30 | 0.62 | 0.75 | 0.13 | 20 | ||
2019-07-29 | 2019-06-30 | 0.75 | 0.8 | 0.05 | 6 | ||
2019-04-30 | 2019-03-31 | 0.75 | 0.85 | 0.1 | 13 | ||
2019-01-29 | 2018-12-31 | 0.63 | 0.64 | 0.01 | 1 | ||
2018-10-30 | 2018-09-30 | 0.75 | 0.78 | 0.03 | 4 | ||
2018-07-31 | 2018-06-30 | 0.74 | 0.81 | 0.07 | 9 | ||
2018-05-01 | 2018-03-31 | 0.74 | 0.77 | 0.03 | 4 | ||
2018-01-30 | 2017-12-31 | 0.56 | 0.62 | 0.06 | 10 | ||
2017-10-31 | 2017-09-30 | 0.64 | 0.67 | 0.03 | 4 | ||
2017-08-01 | 2017-06-30 | 0.66 | 0.67 | 0.01 | 1 | ||
2017-05-02 | 2017-03-31 | 0.67 | 0.69 | 0.02 | 2 | ||
2017-01-31 | 2016-12-31 | 0.5 | 0.47 | -0.03 | 6 | ||
2016-11-01 | 2016-09-30 | 0.62 | 0.61 | -0.01 | 1 | ||
2016-08-02 | 2016-06-30 | 0.62 | 0.64 | 0.02 | 3 | ||
2016-05-03 | 2016-03-31 | 0.55 | 0.67 | 0.12 | 21 | ||
2016-02-02 | 2015-12-31 | 0.52 | 0.53 | 0.01 | 1 | ||
2015-10-27 | 2015-09-30 | 0.51 | 0.6 | 0.09 | 17 | ||
2015-07-28 | 2015-06-30 | 0.52 | 0.56 | 0.04 | 7 | ||
2015-04-28 | 2015-03-31 | 0.49 | 0.51 | 0.02 | 4 | ||
2015-01-27 | 2014-12-31 | 0.53 | 0.54 | 0.01 | 1 | ||
2014-10-28 | 2014-09-30 | 0.55 | 0.57 | 0.02 | 3 | ||
2014-07-29 | 2014-06-30 | 0.57 | 0.58 | 0.01 | 1 | ||
2014-05-05 | 2014-03-31 | 0.55 | 0.57 | 0.02 | 3 | ||
2014-01-28 | 2013-12-31 | 0.52 | 0.56 | 0.04 | 7 | ||
2013-10-29 | 2013-09-30 | 0.56 | 0.58 | 0.02 | 3 | ||
2013-07-30 | 2013-06-30 | 0.55 | 0.56 | 0.01 | 1 | ||
2013-04-30 | 2013-03-31 | 0.55 | 0.54 | -0.01 | 1 | ||
2013-01-29 | 2012-12-31 | 0.44 | 0.47 | 0.03 | 6 | ||
2012-11-01 | 2012-09-30 | 0.53 | 0.53 | 0.0 | 0 | ||
2012-07-31 | 2012-06-30 | 0.54 | 0.62 | 0.08 | 14 | ||
2012-05-01 | 2012-03-31 | 0.56 | 0.58 | 0.02 | 3 | ||
2012-01-31 | 2011-12-31 | 0.47 | 0.5 | 0.03 | 6 | ||
2011-11-01 | 2011-09-30 | 0.56 | 0.62 | 0.06 | 10 | ||
2011-08-02 | 2011-06-30 | 0.59 | 0.6 | 0.01 | 1 | ||
2011-05-03 | 2011-03-31 | 0.59 | 0.6 | 0.01 | 1 | ||
2011-02-01 | 2010-12-31 | 0.46 | 0.47 | 0.01 | 2 | ||
2010-11-02 | 2010-09-30 | 0.51 | 0.54 | 0.03 | 5 | ||
2010-08-03 | 2010-06-30 | 0.52 | 0.62 | 0.1 | 19 | ||
2010-05-04 | 2010-03-31 | 0.53 | 0.6 | 0.07 | 13 | ||
2010-02-03 | 2009-12-31 | 0.5 | 0.49 | -0.01 | 2 | ||
2009-10-20 | 2009-09-30 | 0.48 | 0.51 | 0.03 | 6 | ||
2009-07-22 | 2009-06-30 | 0.47 | 0.48 | 0.01 | 2 | ||
2009-04-28 | 2009-03-31 | 0.49 | 0.54 | 0.05 | 10 | ||
2009-01-26 | 2008-12-31 | 0.59 | 0.65 | 0.06 | 10 | ||
2008-10-21 | 2008-09-30 | 0.6 | 0.62 | 0.02 | 3 | ||
2008-07-23 | 2008-06-30 | 0.54 | 0.55 | 0.01 | 1 | ||
2008-04-17 | 2008-03-31 | 0.66 | 0.61 | -0.05 | 7 | ||
2008-01-23 | 2007-12-31 | 0.47 | 0.52 | 0.05 | 10 | ||
2007-10-18 | 2007-09-30 | 0.53 | 0.58 | 0.05 | 9 | ||
2007-07-18 | 2007-06-30 | 0.5 | 0.42 | -0.08 | 16 | ||
2007-04-20 | 2007-03-31 | 0.57 | 0.68 | 0.11 | 19 | ||
2007-01-22 | 2006-12-31 | 0.42 | 0.43 | 0.01 | 2 | ||
2006-10-19 | 2006-09-30 | 0.45 | 0.54 | 0.09 | 20 | ||
2006-07-20 | 2006-06-30 | 0.48 | 0.5 | 0.02 | 4 | ||
2006-04-19 | 2006-03-31 | 0.53 | 0.61 | 0.08 | 15 | ||
2006-01-19 | 2005-12-31 | 0.42 | 0.51 | 0.09 | 21 | ||
2005-10-20 | 2005-09-30 | 0.48 | 0.51 | 0.03 | 6 | ||
2005-07-20 | 2005-06-30 | 0.44 | 0.46 | 0.02 | 4 | ||
2005-04-19 | 2005-03-31 | 0.53 | 0.54 | 0.01 | 1 | ||
2005-01-19 | 2004-12-31 | 0.59 | 0.58 | -0.01 | 1 | ||
2004-10-20 | 2004-09-30 | 0.54 | 0.55 | 0.01 | 1 | ||
2004-07-21 | 2004-06-30 | 0.47 | 0.47 | 0.0 | 0 | ||
2004-04-20 | 2004-03-31 | 0.51 | 0.52 | 0.01 | 1 | ||
2004-01-22 | 2003-12-31 | 0.51 | 0.53 | 0.02 | 3 | ||
2003-10-22 | 2003-09-30 | 0.44 | 0.47 | 0.03 | 6 | ||
2003-07-25 | 2003-06-30 | 0.29 | 0.3 | 0.01 | 3 | ||
2003-04-22 | 2003-03-31 | 0.44 | 0.45 | 0.01 | 2 | ||
2003-01-22 | 2002-12-31 | 0.47 | 0.48 | 0.01 | 2 | ||
2002-10-16 | 2002-09-30 | 0.39 | 0.39 | 0.0 | 0 | ||
2002-07-15 | 2002-06-30 | 0.32 | 0.33 | 0.01 | 3 | ||
2002-04-17 | 2002-03-31 | 0.39 | 0.39 | 0.0 | 0 | ||
2002-01-23 | 2001-12-31 | 0.34 | 0.34 | 0.0 | 0 | ||
2001-10-17 | 2001-09-30 | 0.33 | 0.34 | 0.01 | 3 | ||
2001-07-17 | 2001-06-30 | 0.29 | 0.3 | 0.01 | 3 | ||
2001-04-18 | 2001-03-31 | 0.31 | 0.33 | 0.02 | 6 | ||
2001-01-24 | 2000-12-31 | 0.27 | 0.27 | 0.0 | 0 | ||
2000-10-24 | 2000-09-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2000-07-24 | 2000-06-30 | 0.22 | 0.23 | 0.01 | 4 | ||
2000-04-18 | 2000-03-31 | 0.25 | 0.28 | 0.03 | 12 | ||
2000-01-18 | 1999-12-31 | 0.23 | 0.25 | 0.02 | 8 | ||
1999-10-19 | 1999-09-30 | 0.21 | 0.23 | 0.02 | 9 | ||
1999-07-19 | 1999-06-30 | 0.17 | 0.19 | 0.02 | 11 | ||
1999-04-15 | 1999-03-31 | 0.21 | 0.21 | 0.0 | 0 | ||
1999-01-19 | 1998-12-31 | 0.17 | 0.18 | 0.01 | 5 | ||
1998-10-13 | 1998-09-30 | 0.19 | 0.17 | -0.02 | 10 | ||
1998-07-09 | 1998-06-30 | 0.15 | 0.17 | 0.02 | 13 | ||
1998-04-14 | 1998-03-31 | 0.18 | 0.18 | 0.0 | 0 | ||
1998-01-20 | 1997-12-31 | 0.14 | 0.14 | 0.0 | 0 | ||
1997-10-14 | 1997-09-30 | 0.15 | 0.15 | 0.0 | 0 | ||
1997-07-15 | 1997-06-30 | 0.12 | 0.12 | 0.0 | 0 | ||
1997-04-15 | 1997-03-31 | 0.16 | 0.16 | 0.0 | 0 | ||
1997-01-16 | 1996-12-31 | 0.13 | 0.13 | 0.0 | 0 | ||
1996-10-14 | 1996-09-30 | 0.13 | 0.13 | 0.0 | 0 | ||
1996-07-17 | 1996-06-30 | 0.1 | 0.1 | 0.0 | 0 | ||
1996-04-16 | 1996-03-31 | 0.13 | 0.14 | 0.01 | 7 | ||
1996-01-17 | 1995-12-31 | 0.11 | 0.11 | 0.0 | 0 | ||
1995-10-15 | 1995-09-30 | 0.11 | 0.11 | 0.0 | 0 |
About Pfizer Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pfizer earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Pfizer estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Pfizer fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Last Reported | Projected for Next Year | ||
Retained Earnings | 118.4 B | 124.3 B | |
Retained Earnings Total Equity | 118.4 B | 87 B | |
Earnings Yield | 0.01 | 0.01 | |
Price Earnings Ratio | 76.67 | 80.50 | |
Price Earnings To Growth Ratio | (0.82) | (0.78) |
Pfizer Investors Sentiment
The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pfizer's public news can be used to forecast risks associated with an investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pfizer's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pfizer.
Pfizer Implied Volatility | 37.22 |
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pfizer Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.